Emerald Health: A Clinically Focused & IP Driven L

SEATTLE, WA--(Marketwired - Feb 1, 2017) - CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article covering Emerald Health Therapeutics Inc. ( TSX VENTURE : EMH ) and its plans to become a leading licensed producer.

Emerald Health is one of only 38 licensed producers under the Access to Cannabis for Medical Purposes Regulations (AMCPR) -- the current regulations, pursuant to the MMAR and MMPR programs. After a lengthy approval process, the company began selling dried medical marijuana during the third quarter of 2015 and cannabis oils in September 2016. Revenue reached around $50,000 during the third quarter of 2016, but is poised to quickly accelerate in 2017 and 2018.

In November, the company signed a letter of intent to lease up to 32 acres of land in Metro Vancouver, British Columbia, which it will use to significantly increase its production of cannabis and cannabis oils. In 2017, management plans to complete a 100,000-square foot expansion in two phases at a cost of $10 million. The expansion will increase production capacity to about 10,000 kilograms per year.

Emerald Health differentiates itself from competing licensed producers with its focus on high-margin opportunities in the space. Rather than simply producing marijuana, the company leverages a very large and diverse library of strains to develop medical products that are backed by clinical studies. The company also continues to allocate funding to research and development activities to ensure that it remains on the cutting-edge of cannabinoid science.

In June 2015, Canada's Supreme Court paved the way for the legalization of cannabis oils and extracts as an alternative to smoking the drug. Emerald Health quickly obtained a license to produce these oils and extracts and launched new products in the space. The company was the first licensed producer to offer THCA extracts, for example, which is a precursor to THC with no psychotropic effects.

Emerald Health's management team has over 100 years of combined experience in cannabis, agriculture, and life sciences industries. For example, President and CEO Bin Huang, PhD, MBA has over 20 years of experience in life sciences; VP of R&D Frey Garabagi, PhD, has over ten years of experience in plant molecular genetics and medtech; and, VP of Production Traviss Graham has over 15 years of experience in cannabis production, processing, and development.

The company's board of directors has also helped raise over $500 million with clinical trials all over the world. For instance, Avtar Dhillon, MD, is Chairman and former CEO of Inovio Pharmaceuticals; Jim Heppell, BSc, LLB, is Director and former CEO of Sophiris Bio Inc.; Bob Rai, BSc, is Chairman and CEO of Canadian Pacific Global Pharmaceuticals; and, Punit Dhillon, BA, is CEO of Oncosec.

Please follow the link to read the full article: http://www.cannabisfn.com/emerald-health-a-cl...-producer/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id...?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Disclaimer: Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/ .